This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ag. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kita-ku, JP (2013)
- Tokyo, JP (2015 - 2023)
Company Filing History:
7 out of 987 
3 out of 5,026 
2 out of 181 
Years Active: 2013-2023
Title: Toshiyuki Morichika: Innovator in Antibody Formulations
Introduction
Toshiyuki Morichika is a prominent inventor based in Tokyo, Japan, known for his contributions to the field of antibody formulations. With a remarkable portfolio of seven patents, he has dedicated much of his work to enhancing the stability and efficacy of therapeutic antibodies.
Latest Patents
Among his latest inventions, Morichika has developed two significant patents focusing on high concentration antibody-containing liquid formulations. These formulations aim to provide a humanized anti-IL-6 receptor antibody AMA and MRA suitable for subcutaneous administration. A critical challenge addressed in these patents is the prevention of dimerization or deamidation during long-term storage. The innovative formulations are characterized by their inclusion of arginine and histidine buffers, which enhance stability and ensure the integrity of the antibodies within.
Career Highlights
Throughout his career, Morichika has contributed to renowned pharmaceutical companies, including Chugai Seiyaku Kabushiki Kaisha and Hoffmann-La Roche Inc. His work within these organizations has positioned him as a key figure in the research and development of innovative antibody therapies.
Collaborations
In his professional journey, Morichika has collaborated with notable colleagues such as Daisuke Kameoka and Yoshimi Imaeda. These collaborations have further enriched his expertise and contributed to the advancements in antibody formulation technologies.
Conclusion
With his dedication to innovation and a solid track record of patents, Toshiyuki Morichika continues to make significant strides in the field of therapeutic antibodies. His efforts not only contribute to the scientific community but also pave the way for enhanced treatment options for patients globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile